Danaher Corp (DHR)

84.10
0.14 0.17
NYSE : Health Care
Prev Close 83.96
Open 84.08
Day Low/High 83.66 / 84.10
52 Wk Low/High 75.71 / 102.79
Volume 684.84K
Avg Volume 2.66M
Exchange NYSE
Shares Outstanding 694.12M
Market Cap 58.27B
EPS 3.70
P/E Ratio 27.17
Div & Yield 0.56 (0.70%)

Latest News

Adding to Danaher

DHR remains below our cost basis and offers us an opportunity here.

Weekly Roundup

FBI firing, French election, oil prices, retail earnings -- and, oh yes, the markets -- create a dizzying week. We add to a few portfolio positions.

Danaher Announces Quarterly Dividend

Danaher Announces Quarterly Dividend

Weekly Roundup

Earnings, the Fed, oil prices, health care legislation: How's that for a busy week? Portfolio moves include adding to our oil positions, taking advantage of volatility.

Weekly Roundup

A big week for earnings helps offset a shaky week elsewhere. Portfolio moves include adding a steel position.

5 Stocks Jim Cramer Likes for the Next 3 Months

5 Stocks Jim Cramer Likes for the Next 3 Months

From Alphabet to Southwest, these names look promising.

Jim Cramer Looks for Growth in Comcast, Southwest and Danaher

Jim Cramer Looks for Growth in Comcast, Southwest and Danaher

A behind the scenes look at Jim Cramer's exclusive conference call with Action Alerts Plus club members, where he breaks down opportunities for growth.

Weekly Roundup

Earnings and hopes for a tax plan help lift the markets. Portfolio moves include exiting a utility position.

Adding Again to Danaher

We believe the earnings-related pullback is overdone and ignores DHR's potential.

Bulking Up on Danaher on This Weakness

We will buy more DHR on this pullback, which we believe will be short-lived.

Danaher Doesn't Disappoint

Overall, we view DHR's first quarter as roughly in line and illustrative of the type of company we want to own in an uncertain market environment.

Market Recon: If You Are Scared, Don't Show It

Market Recon: If You Are Scared, Don't Show It

The market's late downside lunge could not all be placed on a high-profile, highly priced Dow stock doing the nasty.

Weekly Roundup

Banks kick off earnings season while market concerns take an international focus. Portfolio moves include a downgrade of a tech stock.

Weekly Roundup

Syria missile strike and U.S. jobs report cap a rugged week for markets. We make several portfolio moves, including a downgrade.

Adding to 2 Positions: One in Industrials, the Other in Health Care

We're taking advantage of weakness to add to Snap On and Danaher.

Weekly Roundup

That was quite a quarter, wasn't it? Portfolio moves include a downgrade of Apple.

Legislative Circus Is Stalling Stocks: Cramer's 'Mad Money' Recap (Thursday 3/23/17)

Legislative Circus Is Stalling Stocks: Cramer's 'Mad Money' Recap (Thursday 3/23/17)

Brouhaha over GOP-led health-care deal is not really threatening the Republic. But you should have an investment plan in place.

Weekly Roundup

Fed's rate hike gives markets a midweek boost. In the portfolio, we trim 1 position and add to 3 others.

Weekly Roundup

After the jobs report, the markets look ahead to the Fed. In the portfolio, we exit a position while adding to 4 others.

3M's an Income Buy That's Going Higher

3M's an Income Buy That's Going Higher

The company that brought us 'Post-it' notes continues to be an attractive income stock.

Weekly Roundup

Markets retreat late in the week while focusing on the Fed and the Trump administration. We add a tech name to the portfolio.

Weekly Roundup

Market shifts attention from earnings to Trump administration plans. Among several portfolio moves, we exit 2 positions.

Analysts' Actions -- Danaher, Goldman Sachs, Goodyear, Wendy's and More

Analysts' Actions -- Danaher, Goldman Sachs, Goodyear, Wendy's and More

Here are Friday's top research calls, including upgrades for Danaher and Wendy's, and downgrades for Goldman Sachs and Goodyear Tire.

Danaher Announces Quarterly Dividend

Danaher Announces Quarterly Dividend